01—Abstract
Summary
Summary of the 10-K filed February 6, 2026. Cited figures are marked; the original filing is the authoritative source.
Mettler-Toledo International Inc. (MTD) reported net sales of $4.03 billiona for 2025, up from $3.87 billion in 2024 and $3.79 billion in 2023.
Net sales rose 4% in U.S. dollars and 3% in local currencies in 2025. The company cited a difficult environment driven by global trade disputes and tariffs, with incremental tariff costs of approximately $50 millionb in 2025 before mitigation. Gross profit as a percentage of net sales declined to 59.4% from 60.1% in 2024, which the filing attributes primarily to increased tariff costs, lower volume tied to prior-year shipping delay recovery, and unfavorable business mix.
Net earnings were $869.2 millionc, and diluted earnings per share were $42.05, compared with $40.48 in 2024. Cash flow from operations was $955.8 million in 2025. Capital expenditures were $107.1 million, and the company spent $800 million repurchasing 646,608 shares.
Total debt was $2.15 billiond at year end, against cash of $66.9 million. The company expects 2026 share repurchases of $825 million to $875 million and capital expenditures of approximately $130 million. Shareholders' equity was negative at $(23.6) million at December 31, 2025, reflecting cumulative repurchases of $9.84 billion in treasury stock.
The filing describes end markets in pharma/biopharma, food, and chemical as still challenged, while management expects benefits from automation, digitalization, and replacement cycles. Laboratory products represented 56% of 2025 net sales and industrial products 39%. Management states that it has implemented various actions to fully offset the effect of current incremental tariffs in 2026, but warns that further tariff changes could adversely affect future results.
02—Key points
Key Highlights
- Net sales of $4.03 billion in 2025, up 4% in U.S. dollars and 3% in local currencies from $3.87 billion in 2024.
- Diluted EPS of $42.05 in 2025 versus $40.48 in 2024; net earnings of $869.2 million; earnings before taxes of $1.05 billion with a reported tax rate of 17%.
- Gross margin fell to 59.4% from 60.1%, driven primarily by roughly $50 million of pre-mitigation tariff costs and unfavorable business mix.
- Operating cash flow of $955.8 million and capital expenditures of $107.1 million in 2025; 2026 capex expected to be approximately $130 million.
- Total debt of $2.15 billion at December 31, 2025, with $536.3 million of additional credit facility borrowings available and 71% of debt at fixed interest rates.
- Repurchased $800 million of common stock in 2025; 2026 repurchase intent is $825 million to $875 million, with $3.66 billion remaining authorization at year end.
- Shareholders' equity was negative $(23.6) million at year end due to cumulative treasury stock purchases of $9.84 billion; the company has historically not paid dividends.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2025filed February 6, 2026Financial Statements
FY2025 against FY2024
| Line item | FY2025FY2024 | Change |
|---|---|---|
| Revenue | $4.03B$3.87B | +4.0% |
| Gross Profit | $2.39B$2.33B | +2.8% |
| R&D Expenses | $199.37M$189.36M | +5.3% |
| SG&A Expenses | $998.31M$936.30M | +6.6% |
| Interest Expense | $68.52M$74.63M | −8.2% |
| Net Income | $869.19M$863.14M | +0.7% |
| EPS (Basic) | $42.17$40.67 | +3.7% |
| EPS (Diluted) | $42.05$40.48 | +3.9% |
| Shares Outstanding (Basic) | 20.61M21.22M | −2.9% |
| Shares Outstanding (Diluted) | 20.67M21.32M | −3.0% |
05—Questions
Frequently Asked Questions
How did Mettler-Toledo perform financially in 2025?
Net sales rose to $4.03 billion from $3.87 billion, a 4% increase in U.S. dollars and 3% in local currencies. Net earnings increased to $869.2 million from $863.1 million, and diluted EPS rose to $42.05 from $40.48. Growth was led by service revenue, which increased 8% in U.S. dollars, and by the industrial business, which grew 6% in U.S. dollars.
What is the main pressure on margins?
Gross profit as a percentage of net sales declined to 59.4% from 60.1%. The filing attributes this mainly to increased tariff costs, lower sales volume related to recovery of prior-year shipping delays, and unfavorable business mix, partly offset by favorable price realization and SternDrive program benefits. Management estimates 2025 tariff costs before mitigation at approximately $50 million and says it has implemented actions to fully offset the effect of current incremental tariffs in 2026.
How is the company returning cash to shareholders and what is its debt position?
The company repurchased $800 million of stock in 2025 and plans to spend $825 million to $875 million in 2026. The Board added $2.75 billion to the program in November 2025, leaving $3.7 billion of remaining availability at year end (the filing also shows $3,658,439 thousand as the remaining dollar value under the program at December 31, 2025). Total debt was $2.15 billion, with $66.9 million of cash. The company has historically not paid dividends and says it will evaluate that policy periodically.
What risks does management highlight for 2026?
Key risks include ongoing tariffs and retaliatory trade measures, with the U.S. having indicated it may change tariff rates further; a significant concentration of business in China, which accounted for 16% of sales to external customers and 29% of total segment profit in 2025; slow recovery in pharma/biopharma, food and chemical end markets; currency fluctuations among the Swiss franc, euro, renminbi and U.S. dollar; and cybersecurity and system dependence tied to the Blue Ocean ERP program.
What growth drivers does management point to?
Management cites market trends toward automation and digitalization, customer replacement cycles, on- and near-shoring investments, and growth in product inspection, process analytics, and service. Service represented approximately 25% of 2025 net sales. Emerging markets accounted for approximately 33% of total net sales, and management plans to pursue bolt-on acquisitions in life sciences and distribution. The company spent $107.1 million in capital expenditures in 2025 and $93.8 million in initial acquisition payments.
06—Continue